Oral Oncology
Volume 45, Issue 12 , Pages 1011-1014 , December 2009

Review of the molecular pathogenesis of the odontogenic keratocyst

Received 13 July 2009 ,Revised 1 August 2009 ,Accepted 17 August 2009.

References 

  1. Odell EW, Morgan PR. Biopsy pathology of the oral tissues. London: Chapman & Hall; 1998;
  2. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours. Pathology & genetics. Head and neck tumours. Lyon: IARC Press; 2005;
  3. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol. 2002;38:219–226
  4. Li TJ, Browne RM, Matthews JB. Quantification of PCNA positive cells within odontogenic jaw cyst epithelium. J Oral Pathol Med. 1994;23:184–189
  5. Slootweg PJ. P53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med. 1995;24:393–397
  6. Li T-J, Browne RM, Matthews JB. Epithelial cell proliferations in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med. 1995;24:221–226
  7. El Murtadi AE, Grehan D, Toner M, McCartan BE. Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:217–220
  8. Piattelli A, Fioroni M, Santinelli A, Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol. 1998;34:408–412
  9. Lo Muzio L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with nevoid basal cell carcinoma syndrome. J Dent Res. 1999;78:1345–1353
  10. Kimi K, Kumamoto H, Ooya K, Motegi K. Immunohistochemical analysis of cell-cycle and apoptosis-related factor in lining epithelium of odontogenic keratocysts. J Oral Pathol Med. 2001;30:434–442
  11. Saraçoglu U, Kurt B, Günhan O, Güven O. MIB-1 expression in odontogenic epithelial rests, epithelium of healthy oral mucosa and epithelium of selected odontogenic cysts. An immunohistochemical study. Int J Oral Maxillofac Surg. 2005;34:432–435
  12. Kolár Z, Geierová M, Bouchal J, Pazdera J, Zboril V, Tyrdý P. Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med. 2006;35:75–80
  13. Souza PEA, Mesquita RA, Gomez RS. Evaluation of p53, PCNA, Ki-67, MDM-2 and AgNOR in oral peripheral and central giant cell lesions. Oral Diseases. 2000;6:35–39
  14. Kaplan I, Anavi Y, Manor R, Sulkes J, Calderon S. The use of molecular markers as an aid in the diagnosis of glandular odontogenic cyst. Oral Oncol. 2005;41:895–902
  15. Agaram NP, Collins B, Barnes L, Lomago D, Aldeeb D, Swalsky P, et al. Molecular analysis to demonstrate that odontogenic keratocyst are neoplastic. Arch Pathol Lab Med. 2004;128:313–317
  16. Henley J, Summerlin D-J, Tomich C, Zhang S, Cheng L. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases. Histopathology. 2005;47:582–586
  17. Malcić A, Jukić S, Anić I, Pavelić B, Kapitanović S, Kruslin B, et al. Alterations of FHIT and P53 genes in keratocystic odontogenic tumour, dentigerous cyst and radicular cyst. J Oral Pathol Med 2008;37:294–301.
  18. Partridge M, Costea DE, Huang X. The changing face of p53 in head and neck cancer. Int J Oral Maxillofac Surg. 2007;36:1123–1138
  19. Lombardi T, Odell EW, Morgan PR. P53 immunohistochemistry of odontogenic keratocyst in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Archs Oral Biol. 1995;40:1081–1084
  20. Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. P53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med. 1996;25:249–255
  21. Clark P, Marker P, Bastian HL, Krogdahl A. Expression of p53, Ki-67, and EGFR in odontogenic keratocysts before and after decompression. J Oral Pathol Med. 2006;35:568–572
  22. Heikinheimo K, Jee KJ, Morgan PR, Nagy B, Knuutila S, Leiva I. Genetic changes in sporadic keratocystic odontogenic tumors (Odontogenic Keratocysts). J Dent Res. 2007;86:544–549
  23. Lench NJ, Telford EA, High AS, Markham AF, Wicking C, Wainwright BJ. Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome. Hum Genet. 1997;100:497–502
  24. Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L. PTCH gene mutations in odontogenic keratocysts. J Dent Res. 2000;79:1418–1422
  25. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K, et al. PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg. 2004;33:584–592
  26. Gu XM, Zhao HS, Sun LS, Li TJ. PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts. J Dent Res. 2006;85:859–863
  27. Sun LS, Li XF, Li TJ. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J Dent Res. 2008;87:575–579
  28. Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 2005;6:306–317
  29. Pan S, Li T-J. PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation? Oral Oncol. doi:10.1016/j.oraloncology.2009.02.003.
  30. Lindström E, Shimokawa T, Toftgård R, Zaphiropoulos PG. PTCH mutations: distribution and analyses. Hum Mutat. 2006;27:215–219
  31. Barreto DC, Bale AE, De Marco L, Gomez RS. Immunolocalization of PTCH protein in odontogenic cysts and tumors. J Dent Res. 2002;81:757–760
  32. Ayoubi TA, Van De Ven WJ. Regulation of gene expression by alternative promoters. FASEB J. 1996;10:453–460
  33. Kogerman P, Krause D, Rahnama F, Kogerman L, Undén AB, Zaphiropoulos PG, et al. Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein. Oncogene. 2002;21:6007–6016
  34. Shimokawa T, Rahnama F, Zaphiropoulos PG. A novel first exon of the Patched1 gene is upregulated by Hedgehog signaling resulting in a protein with pathway inhibitory functions. FEBS Lett. 2004;578:157–162
  35. Agren M, Kogerman P, Kleman MI, Wessling M, Toftgård R. Expression of the PTCH1 tumour suppressor gene is regulated by alternative promoters and a single functional Gli-binding site. Gene. 2004;330:101–114
  36. Nagao K, Toyoda M, Takeuchi-Inoue K, Fujii K, Yamada M, Miyashita T. Identification and characterization of multiple isoforms of a murine and human tumour suppressor, patched, having distinct first exons. Genomics. 2005;85:462–471
  37. Shimokawa T, Svärd J, Heby-Henricson K, Teglund S, Toftgård R, Zaphiropoulos PG. Distinct roles of first exon variants of the tumour-suppressor Patched1 in Hedgehog signaling. Oncogene. 2007;26:4889–4896
  38. Diniz MG, Borges ER, Guimarães ALS, Moreira PR, Brito JAR, Gomez MV, et al. PTCH1 isoforms in odontogenic keratocysts. Oral Oncol. 2009;45:291–295
  39. Weber A, Wittekind C, Tannapfel A. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of head and neck. Pathol Res Pract. 2003;199:391–397
  40. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nat Rev Genet. 2000;1:11–19
  41. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002;108:475–487
  42. Cretnik M, Musani V, Oreskovic S, Leovic D, Levanat S. The Patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas. Int J Mol Med. 2007;19:875–883
  43. Pritchard JE, Olson JM. Methylation of PTCH1, the Patched 1 gene, in a panel of medulloblastoma. Cancer Genet Cytogenet. 2008;180:47–50
  44. Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, et al. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat. 2007;105:139–155
  45. Rocha PR, Guimarães MM, Guimarães ALS, Diniz MG, Gomes CC, Brito JAR, et al. Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts. J Oral Pathol Med. 2009;38:99–103
  46. Chen CZ. MicroRNAs as oncogenes and tumour suppressors. N Engl J Med. 2005;353:1768–1771
  47. Gomes CC, Gomez RS. MicroRNA and oral cancer: future perspectives. Oral Oncol. 2008;44:910–914

PII: S1368-8375(09)00884-7

doi: 10.1016/j.oraloncology.2009.08.003

Oral Oncology
Volume 45, Issue 12 , Pages 1011-1014 , December 2009

Article Tools

* Image Usage & Resolution